Comparisons with state-of-the-art methods demonstrate the enhanced performance of DFRL-Mol in multiple scenarios of molecule optimization, including SO optimization, substructure-constrained (SC) SO optimization, MO optimization, and MO molecule generation.
Abstract
Abstract As a critical step in drug discovery, molecule optimization aims to improve specific properties of lead compounds. Inspired by isosteres (i.e. molecular substructures with similar reactive electron shells), existing AI-based methods have been proposed for molecule optimization. However, they often rely on available matched molecular pairs (MMPs), thus facing two essential challenges. First, the limited diversity of available MMPs leads to biased training and a lack of novelty in the optimized molecules, in both single-objective (SO) and multi-objective (MO) optimization. Second, the low number of available MMPs leads to limited generalization in MO optimization. To overcome the limitations of MMPs, we propose DFRL-Mol, a novel dual-stage reinforcement learning framework. It consists of three main modules: the Structure–Property Analyst (SPA), the Decorator (DCR), and Curriculum-guided Dual-Stage Policy Optimization (CDSPO). SPA and DCR are two LLM-based models, which are responsible for locating the substructures to be optimized and inferring their appropriate isosteric replacement, respectively. CDSPO leverages curriculum-guided reinforcement learning to facilitate collaboration between the two models. DFRL-Mol ensures the generation of diverse molecular representations while effectively overcoming the issues of bias and data sparsity associated with MMPs. The comparisons with state-of-the-art methods demonstrate the enhanced performance of DFRL-Mol in multiple scenarios of molecule optimization, including SO optimization, substructure-constrained (SC) SO optimization, MO optimization, and MO molecule generation. More importantly, detailed analysis of experimental results demonstrates that the models’ behavior is consistent with chemical intuition.
Generative artificial intelligence (AI) holds transformative potential for drug discovery, yet existing architectures typically operate in open loops without experimental feedback. Here we introduce rapid compound directed optimization (RCDO), a closed-loop reinforcement learning framework that accelerates the optimiza...
Han Wang, Dehua Lu, Weiping Lyu et al.· bioRxiv· 0 citations
POLO (Preference-guided Optimization for Lead Optimization), a multi-turn Reinforcement Learning framework for sample-efficient lead optimization, which extracts learning signals from each trajectory at two complementary levels: trajectory-level policy optimization reinforces successful multi-turn strategies, while tur...
Ziqing Wang, Yibo Wen, William Pattie et al.· Proceedings of the 32nd ACM...· 0 citations
This work introduces MARCO, an evaluator-grounded reinforcement-learning framework that trains molecular editors on bounded proposal--feedback--revision trajectories and aggregates shaped turn rewards into an undiscounted trajectory return for group-relative policy optimization.
Shi-Cheng Fang, Yu-Xin Wang, Zhuo Yang et al.· 0 citations
PGFS++ is introduced, a synthesis-aware reinforcement learning framework for input-specific molecular improvement that improves target properties while preserving high output diversity, and experiments show that PGFS++ improves target properties while preserving high output diversity.
Bo-Qi Zhang, G. James, S. Gottipati et al.· 0 citations
CRAFT is a reaction-aware molecular optimization framework that integrates Monte Carlo Tree Search (MCTS) with a multimodal strategy network and explicitly encodes two-dimensional molecular topology and atom-level reaction roles, enabling chemically feasible transformations during multi-step optimization.
Run-Fu Yu, Tong-Mao Ma, Zian Song et al.· Journal of Medicinal Chemist...· 0 citations
PockLigGPT achieves competitive docking-oriented performance under a standardized evaluation protocol while maintaining chemical plausibility, favorable physicochemical profiles, and Lipinski-based drug-likeness.
Pablo Varas Pardo, Guillermo Marcos-Ayuso, Eugenia Ulzurrun et al.· Journal of Chemical Informat...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.